Cricut, Inc. - CRCT

CRCT Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
CRCT	-4.0	-7.8	-17.3	-9.7	-28.9	-30	-79.3	-70.1	-70.1	-70.1
S&P 500	-0.3	-0.1	1.9	9.4	13.8	32.8	27.5	92.8	192.7	33707.2

Compare CRCT with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	CRCT
name	Cricut, Inc.
price	5.32
changes percentage	-3.9711
change	-0.22
day low	5.305
day high	5.595
year high	8.4
year low	4.43
market cap	1140998360
price avg 50	6.348
price avg 200	5.86095
exchange	NASDAQ
volume	90608
avg volume	366664
open	5.54
previous close	5.54
eps	0.29
pe	18.34
earnings announcement	2025-03-04T05:00:00.000+0000
shares outstanding	214473376
timestamp	2024-11-14 17:01:18

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 35.3%

Overall Quarterly Financial Health: 35.0%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0001828962
revenue	765147000	886296000	-13.67
gross profit	343293000	349893000	-1.89
gross profit ratio	0.45	0.39	13.65
research and development expenses	65048000	76914000	-15.43
operating expenses	273308000	269940000	1.25
interest income	7976000	1809000	340.91
interest expense	323000	289000	11.76
ebitda	109906000	109832000	0.07
ebitdaratio	0.13	0.12	8.11
operating income	69985000	79953000	-12.47
operating income ratio	0.09	0.09	1.39
net income	53636000	60666000	-11.59
net income ratio	0.07	0.07	2.41
eps	0.25	0.28	-10.71

Overall Score of Annual Income Statement

0.12 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 765 million in 2023 from 886 million in 2022 representing a change of -13.67%. This indicates a sales shrinking, which is a negative sign for the company.

  Gross Profit: Gross Profit decreased to 343 million in 2023 from 350 million in 2022 representing a change of -1.89%. This indicates a sales profitability decline, which is a negative sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses decreased to 65 million in 2023 from 77 million in 2022 representing a change of -15.43%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  Operating Expenses: Operating Expenses increased to 273 million in 2023 from 270 million in 2022 representing a change of 1.25%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  Operating Income: Operating income decreased to 70 million in 2023 from 80 million in 2022 representing a change of -12.47%. The decrease in operating income indicates worse operational performance and decreased profitability.

  Net Income: Net income decreased to 54 million in 2023 from 61 million in 2022 representing a change of -11.59%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 0.25 in 2023 from 0.25 in 2022 representing a change of -10.71%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

• 📈 Positive Indicators

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 110 million in 2023 from 110 million in 2022 representing a change of 0.07%. The increase in EBITDA indicates improved operational efficiency and profitability.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0001828962
revenue	167890000	167947000	-0.03
gross profit	77363000	89840000	-13.89
gross profit ratio	0.46	0.53	-13.86
research and development expenses	15240000	14315000	6.46
operating expenses	66767000	63408000	5.30
interest income	2718000	3053000	-10.97
interest expense	84000	80000	5.00
ebitda	21460000	34030000	-36.94
ebitdaratio	0.06	0.2	-68.85
operating income	10596000	26432000	-59.91
operating income ratio	0.06	0.16	-59.90
net income	11488000	19769000	-41.89
net income ratio	0.07	0.12	-41.87
eps	0.05	0.09	-41.40

Overall Score of Quarterly Income Statement

0.12 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 168 million in 2024Q3 from 168 million in 2024Q2 representing a change of -0.03%. This indicates a sales shrinking, which is a negative sign for the company.

  Gross Profit: Gross Profit decreased to 77 million in 2024Q3 from 90 million in 2024Q2 representing a change of -13.89%. This indicates a sales profitability decline, which is a negative sign for the company.

  Operating Expenses: Operating Expenses increased to 67 million in 2024Q3 from 63 million in 2024Q2 representing a change of 5.3%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 21 million in 2024Q3 from 34 million in 2024Q2 representing a change of -36.94%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Operating Income: Operating income decreased to 11 million in 2024Q3 from 26 million in 2024Q2 representing a change of -59.91%. The decrease in operating income indicates worse operational performance and decreased profitability.

  Net Income: Net income decreased to 11 million in 2024Q3 from 20 million in 2024Q2 representing a change of -41.89%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 0.05 in 2024Q3 from 0.05 in 2024Q2 representing a change of -41.4%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

• 📈 Positive Indicators

  Research and Development (R&D) Expenses: R&D Expenses increased to 15 million in 2024Q3 from 14 million in 2024Q2 representing a change of 6.46%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0001828962
total assets	761593000	949627000	-19.80
total liabilities	226720000	276892000	-18.12
total equity	534873000	672735000	-20.49
cash and cash equivalents	142187000	224943000	-36.79
short term investments	102952000	74256000	38.64
long term investments	0	0	NaN
total current assets	619969000	811262000	-23.58
total non current assets	141623999	138365000	2.36
total current liabilities	196464000	254056000	-22.67
total non current liabilities	30256000	22836000	32.49
common stock	218000	220000	-0.91
retained earnings	28514000	0	NaN
total debt	14168000	19371000	-26.86

Overall Score of Annual Balance Sheet

0.5 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Total Assets: Total Assets decreased to 762 million in 2023 from 950 million in 2022 representing a change of -19.8%. Suggesting a decrease in asset holdings.

  Total Equity: Total Equity decreased to 535 million in 2023 from 673 million in 2022 representing a change of -20.49%. This indicates a decrease in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 142 million in 2023 from 225 million in 2022 representing a change of -36.79%. This indicates a decrease in available liquid assets.

  Total Current Assets: Total Current Assets decreased to 620 million in 2023 from 811 million in 2022 representing a change of -23.58%. This indicates a worsen liquidity position.

  Common Stock: Common Stock decreased to 0 in 2023 from 0 in 2022 representing a change of -0.91%. This indicates a decrease in ownership interest.

• 📈 Positive Indicators

  Total Liabilities: Total Liabilities decreased to 227 million in 2023 from 277 million in 2022 representing a change of -18.12%. This indicates a decrease in overall liabilities.

  Short Term Investments: Short Term Investments increased to 103 million in 2023 from 74 million in 2022 representing a change of 38.64%. This indicates an increase in short-term investment holdings.

  Total Current Liabilities: Total Current Liabilities decreased to 196 million in 2023 from 254 million in 2022 representing a change of -22.67%. This indicates a lower short-term debt burden.

  Retained Earnings: Retained Earnings increased to 29 million in 2023 from 0 million in 2022 representing a change of nan%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 14 million in 2023 from 19 million in 2022 representing a change of -26.86%. This indicates a reduction in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0001828962
total assets	663765000	742111000	-10.56
total liabilities	187929000	293567000	-35.98
total equity	475836000	448544000	6.08
cash and cash equivalents	142376000	195552000	-27.19
short term investments	104566000	103907000	0.63
long term investments	0	0	NaN
total current assets	540757000	611151000	-11.52
total non current assets	123008000	130960000	-6.07
total current liabilities	171311000	276262000	-37.99
total non current liabilities	16618000	17305000	-3.97
common stock	214000	216000	-0.93
retained earnings	11488000	0	NaN
total debt	10459000	11826000	-11.56

Overall Score of Quarterly Balance Sheet

0.6 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Total Assets: Total Assets decreased to 664 million in 2024Q3 from 742 million in 2024Q2 representing a change of -10.56%. Suggesting a decrease in asset holdings.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 142 million in 2024Q3 from 196 million in 2024Q2 representing a change of -27.19%. This indicates a decrease in available liquid assets.

  Total Current Assets: Total Current Assets decreased to 541 million in 2024Q3 from 611 million in 2024Q2 representing a change of -11.52%. This indicates a worsen liquidity position.

  Common Stock: Common Stock decreased to 0 in 2024Q3 from 0 in 2024Q2 representing a change of -0.93%. This indicates a decrease in ownership interest.

• 📈 Positive Indicators

  Total Liabilities: Total Liabilities decreased to 188 million in 2024Q3 from 294 million in 2024Q2 representing a change of -35.98%. This indicates a decrease in overall liabilities.

  Total Equity: Total Equity increased to 476 million in 2024Q3 from 449 million in 2024Q2 representing a change of 6.08%. This indicates an increase in shareholders' equity.

  Short Term Investments: Short Term Investments increased to 105 million in 2024Q3 from 104 million in 2024Q2 representing a change of 0.63%. This indicates an increase in short-term investment holdings.

  Total Current Liabilities: Total Current Liabilities decreased to 171 million in 2024Q3 from 276 million in 2024Q2 representing a change of -37.99%. This indicates a lower short-term debt burden.

  Retained Earnings: Retained Earnings increased to 11 million in 2024Q3 from 0 million in 2024Q2 representing a change of nan%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 10 million in 2024Q3 from 12 million in 2024Q2 representing a change of -11.56%. This indicates a reduction in overall debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0001828962
net change in cash	-82756000	-16654000	-396.91
operating cash flow	288097000	117683000	144.81
free cash flow	264380000	83912000	215.07
capital expenditure	-23717000	-33771000	29.77
depreciation and amortization	29800000	26957000	10.55
deferred income tax	-11238000	-20461000	45.08
stock based compensation	47326000	41121000	15.09
accounts payables	13535000	-139845000	109.68
inventory	78376000	63085000	24.24
acquisitions net	25061000	74098000	-66.18
investments in property plant and equipment	-23717000	-33771000	29.77
net cash used for investing activites	-48778000	-107869000	54.78
debt repayment	0	0	NaN
common stock issued	0	0	NaN
common stock repurchased	-20332000	-18580000	-9.43
dividends paid	-294130000	0	NaN
net cash used provided by financing activities	-322185000	-26247000	-1127.51
cash at end of period	142187000	224943000	-36.79
accounts receivables	23500000	63696000	-63.11
cash at beginning of period	224943000	241597000	-6.89

Overall Score of Annual Cashflow Statement

0.44 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to -83 million in 2023 from -17 million in 2022 representing a change of -396.91%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

  Capital Expenditure: Capital Expenditure increased to -24 million in 2023 from -34 million in 2022 representing a change of 29.77%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Deferred Income Tax: Deferred Income Tax increased to -11 million in 2023 from -20 million in 2022 representing a change of 45.08%. This indicates that the company's tax liability for future periods has increased.

  Stock-Based Compensation: Stock-Based Compensation increased to 47 million in 2023 from 41 million in 2022 representing a change of 15.09%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

  Dividends Paid: Dividends Paid decreased to -294 million in 2023 from 0 million in 2022 representing a change of nan%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• 📈 Positive Indicators

  Operating Cash Flow: Operating Cash Flow increased to 288 million in 2023 from 118 million in 2022 representing a change of 144.81%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 264 million in 2023 from 84 million in 2022 representing a change of 215.07%. This indicates an increase in cash generated after accounting for capital expenditures.

  Accounts Payables: The absolute value of Accounts Payables decreased to 14 million in 2023 from 140 million in 2022 representing a change of 109.68%. This indicates that the company has reduced its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables decreased to 24 million in 2023 from 64 million in 2022 representing a change of -63.11%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0001828962
operating cash flow	70237000	34960000	100.91
free cash flow	65758000	30114000	118.36
capital expenditure	-4479000	-4846000	7.57
depreciation and amortization	7214000	7598000	-5.05
deferred income tax	-2532001	-5344000	52.62
stock based compensation	11879000	10619000	11.87
accounts receivables	-9259000	-4691000	-97.38
accounts payables	11425000	-10964000	204.20
inventory	29355000	36079000	-18.64
acquisitions net	0	0	NaN
investments in property plant and equipment	-4479000	-4846000	7.57
net cash used for investing activites	-4471000	-4846000	7.74
debt repayment	0	0	NaN
common stock issued	0	0	NaN
common stock repurchased	-10380000	-9308000	-11.52
dividends paid	-108228000	-108000	-100111.11
net cash used provided by financing activities	-119211000	-13549000	-779.85
net change in cash	-53176000	16560000	-421.11
cash at end of period	142376000	195552000	-27.19
cash at beginning of period	195552000	178992000	9.25

Overall Score of Quarterly Cashflow Statement

0.33 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to -53 million in 2024Q3 from 17 million in 2024Q2 representing a change of -421.11%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

  Capital Expenditure: Capital Expenditure increased to -4 million in 2024Q3 from -5 million in 2024Q2 representing a change of 7.57%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Deferred Income Tax: Deferred Income Tax increased to -3 million in 2024Q3 from -5 million in 2024Q2 representing a change of 52.62%. This indicates that the company's tax liability for future periods has increased.

  Stock-Based Compensation: Stock-Based Compensation increased to 12 million in 2024Q3 from 11 million in 2024Q2 representing a change of 11.87%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

  Accounts Payables: The absolute value of Accounts Payables increased to 11 million in 2024Q3 from 11 million in 2024Q2 representing a change of 204.2%. This indicates that the company has increased its outstanding obligations to its suppliers.

  Dividends Paid: Dividends Paid decreased to -108 million in 2024Q3 from 0 million in 2024Q2 representing a change of -100111.11%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• 📈 Positive Indicators

  Operating Cash Flow: Operating Cash Flow increased to 70 million in 2024Q3 from 35 million in 2024Q2 representing a change of 100.91%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 66 million in 2024Q3 from 30 million in 2024Q2 representing a change of 118.36%. This indicates an increase in cash generated after accounting for capital expenditures.

  Accounts Receivables: Accounts Receivables decreased to -9 million in 2024Q3 from -5 million in 2024Q2 representing a change of -97.38%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

Earnings Transcripts ⓘ

We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.

Note: The years mentioned below are fiscal years in accounting.

Q3 2024 Earnings call transcript
Q2 2024 Earnings call transcript
Q1 2024 Earnings call transcript
Q4 2023 Earnings call transcript
Q3 2023 Earnings call transcript
Q2 2023 Earnings call transcript
Q1 2023 Earnings call transcript
Q4 2022 Earnings call transcript

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	3.53	4.13	-14.64
net income per share	0.25	0.28	-12.58
operating cash flow per share	1.33	0.55	142.06
free cash flow per share	1.22	0.39	211.53
cash per share	1.13	1.4	-18.99
book value per share	2.47	3.14	-21.39
tangible book value per share	2.47	3.13	-21.30
shareholders equity per share	2.47	3.14	-21.39
interest debt per share	0.03	0.03	-4.09
market cap	1429321739.75	1988028292.68	-28.10
enterprise value	1301302739.75	1782456292.68	-26.99
pe ratio	26.65	32.77	-18.68
price to sales ratio	1.87	2.24	-16.72
pocfratio	4.96	16.89	-70.63
pfcf ratio	5.41	23.69	-77.18
pb ratio	2.67	2.96	-9.57
ptb ratio	2.67	2.96	-9.57
ev to sales	1.7	2.01	-15.43
enterprise value over ebitda	11.84	16.23	-27.04
ev to operating cash flow	4.52	15.15	-70.18
ev to free cash flow	4.92	21.24	-76.83
earnings yield	0.04	0.03	22.97
free cash flow yield	0.18	0.04	338.22
debt to equity	0.01	0.01	21.01
debt to assets	0.01	0.01	19.96
net debt to ebitda	-1.16	-1.87	37.77
current ratio	3.16	3.19	-1.18
interest coverage	216.67	276.65	-21.68
income quality	5.37	1.94	176.89
dividend yield	0.21	0	NaN
payout ratio	5.48	0	NaN
sales general and administrative to revenue	0.11	0.07	57.33
research and ddevelopement to revenue	0.09	0.09	-2.04
intangibles to total assets	0	0.0	-100.00
capex to operating cash flow	0.08	0.29	-71.31
capex to revenue	0.03	0.04	-18.65
capex to depreciation	0.8	1.25	-36.47
stock based compensation to revenue	0.06	0.05	33.31
graham number	3.7	4.47	-17.10
roic	0.09	0.09	-0.15
return on tangible assets	0.07	0.06	10.15
graham net net	1.03	1.4	-26.28
working capital	423505000	557206000	-23.99
tangible asset value	534873000	671975000	-20.40
net current asset value	393249000	534370000	-26.41
invested capital	483472000	638451000	-24.27
average receivables	123893000	168023500	-26.26
average payables	70027500	133954500	-47.72
average inventory	298075500	402928000	-26.02
days sales outstanding	53.07	56.23	-5.62
days payables outstanding	66.5	43.0	54.65
days of inventory on hand	211.52	239.31	-11.61
receivables turnover	6.88	6.49	5.96
payables turnover	5.49	8.49	-35.34
inventory turnover	1.73	1.53	13.14
roe	0.1	0.09	11.20
capex per share	0.11	0.16	-30.56

• ROE:

• Negative

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 26.65 on 2023-12-31 from 32.77 on 2022-12-31, representing a change of -18.68%. Indicating a decrease in the relative valuation of the company's stock.

  Current Ratio: Current Ratio decreased to 3.16 on 2023-12-31 from 3.19 on 2022-12-31, representing a change of -1.18%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. Since it's above 3, indicating poor management of working capital.

• Positive

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.01 on 2023-12-31 from 0.01 on 2022-12-31, representing a change of 21.01%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Quarterly Financial Ratios

	2024-09-30 Q3	2024-06-30 Q2	Q/Q change %
CRCT
calendar year	2024	2024	NaN
revenue per share	0.78	0.78	0.74
net income per share	0.05	0.09	-41.44
operating cash flow per share	0.33	0.16	102.45
free cash flow per share	0.31	0.14	120.04
cash per share	1.15	1.38	-16.90
book value per share	2.22	2.07	6.90
tangible book value per share	2.22	2.07	6.90
shareholders equity per share	2.22	2.07	6.90
interest debt per share	0.02	0.02	-6.52
market cap	1488349620.45	1201144947.15	23.91
enterprise value	1356432620.45	1017418947.15	33.32
pe ratio	32.39	15.19	113.23
price to sales ratio	8.87	7.15	23.95
pocfratio	21.19	34.36	-38.32
pfcf ratio	22.63	39.89	-43.25
pb ratio	3.13	2.68	16.80
ptb ratio	3.13	2.68	16.80
ev to sales	8.08	6.06	33.37
enterprise value over ebitda	63.21	29.9	111.41
ev to operating cash flow	19.31	29.1	-33.64
ev to free cash flow	20.63	33.79	-38.95
earnings yield	0.01	0.02	-53.10
free cash flow yield	0.04	0.03	76.23
debt to equity	0.01	0.01	-12.74
debt to assets	0.01	0.01	3.49
net debt to ebitda	-6.15	-5.4	-13.86
current ratio	3.16	2.21	42.69
interest coverage	126.14	330.4	-61.82
income quality	6.11	1.77	245.73
dividend yield	0.07	0.0	80773.52
payout ratio	9.42	0.01	172347.20
sales general and administrative to revenue	0.1	0.09	3.28
research and ddevelopement to revenue	0.09	0.09	6.50
intangibles to total assets	0	0	NaN
capex to operating cash flow	0.06	0.14	-54.00
capex to revenue	0.03	0.03	-7.54
capex to depreciation	0.62	0.64	-2.65
stock based compensation to revenue	0.07	0.06	11.90
graham number	1.63	2.06	-20.88
roic	0.02	0.04	-53.74
return on tangible assets	0.02	0.03	-35.03
graham net net	0.99	0.76	30.02
working capital	369446000	334889000	10.32
tangible asset value	475836000	448544000	6.08
net current asset value	352828000	317584000	11.10
invested capital	418285000	387249000	8.01
average receivables	88527000	80674500	9.73
average payables	39749000	39590000	0.40
average inventory	179921500	208853500	-13.85
days sales outstanding	50.02	44.88	11.44
days payables outstanding	45.26	39.15	15.61
days of inventory on hand	166.53	221.63	-24.86
receivables turnover	1.8	2.01	-10.27
payables turnover	1.99	2.3	-13.50
inventory turnover	0.54	0.41	33.09
roe	0.02	0.04	-45.22
capex per share	0.02	0.02	-6.86

• Negative

  ROE: Return on Equity (ROE) decreased to 0.02 on 2024-09-30 Q3 from 0.04 on 2024-06-30 Q2, representing a change of -45.22%. Suggesting that the company has not been generating high returns for its shareholders.

  Current Ratio: Current Ratio increased to 3.16 on 2024-09-30 Q3 from 2.21 on 2024-06-30 Q2, representing a change of 42.69%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Since it's above 3, indicating poor management of working capital.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 32.39 on 2024-09-30 Q3 from 15.19 on 2024-06-30 Q2, representing a change of 113.23%. Indicating an increase in the relative valuation of the company's stock.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.01 on 2024-09-30 Q3 from 0.01 on 2024-06-30 Q2, representing a change of -12.74%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

None